Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Circulating Tumor DNA × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 Genitourinary 2 CNS 2 Thoracic 1 Sarcoma 1 Head & Neck 1 Gynecologic 1

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 486 Carboplatin 447 Cisplatin 288 Bevacizumab 212 pembrolizumab 192 Gemcitabine 124 Cyclophosphamide 111 olaparib 104 Topotecan 101 liposomal doxorubicin 100 Radiotherapy 94 Taxes 87 Docetaxel 79 Brachytherapy 78 Doxorubicin 72 Drug Therapy 71 niraparib 63 Nivolumab 61 Magnetic Resonance Spectroscopy 56 Specimen Handling 55 fludarabine 51 Biopsy 49 Hyperthermic Intraperitoneal Chemotherapy 44 Filgrastim 42 durvalumab 41 Letrozole 41 Platinum 37 Oxaliplatin 37 atezolizumab 36 Radiation 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04846933 2025-01-16

DECIDER

Turku University Hospital

Phase NA Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡